Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

recurrence

  • Borderline Findings in <em>O</em>-(2-[<sup>18</sup>F]-Fluoroethyl)-<span class="sc">l</span>-Tyrosine PET of Patients with Suspected Glioma Relapse: Role in Clinical Practice
    You have access
    Borderline Findings in O-(2-[18F]-Fluoroethyl)-l-Tyrosine PET of Patients with Suspected Glioma Relapse: Role in Clinical Practice
    Karl-Josef Langen, Gabriele Stoffels, Christian P. Filss, Martin Kocher, Christoph Lerche, Michael Sabel, Marion Rapp, Hosai Noltemeier, Jan-Michael Werner, Garry Ceccon, Michael M. Wollring, Jurij Rosen, Joachim P. Steinbach, Elke Hattingen, Martin R. Weinzierl, Michael Stoffel, Hans Clusmann, N. Jon Shah, Felix M. Mottaghy, Norbert Galldiks and Philipp Lohmann
    Journal of Nuclear Medicine February 1, 2025, 66 (2) 187-193; DOI: https://doi.org/10.2967/jnumed.124.268768
  • Association Between CA 15-3 and <sup>18</sup>F-FDG PET/CT Findings in Recurrent Breast Cancer Patients at a Tertiary Referral Hospital in Kenya
    You have access
    Association Between CA 15-3 and 18F-FDG PET/CT Findings in Recurrent Breast Cancer Patients at a Tertiary Referral Hospital in Kenya
    Margaret M. Mwania, Samuel Nguku Gitau, Jasmit Shah and Khalid Makhdomi
    Journal of Nuclear Medicine October 1, 2024, 65 (10) 1521-1525; DOI: https://doi.org/10.2967/jnumed.124.267851
  • Diagnostic Performance of <sup>68</sup>Ga-PSMA-11 PET/CT Versus Multiparametric MRI for Detection of Intraprostatic Radiorecurrent Prostate Cancer
    You have access
    Diagnostic Performance of 68Ga-PSMA-11 PET/CT Versus Multiparametric MRI for Detection of Intraprostatic Radiorecurrent Prostate Cancer
    Alexander Light, Stefan Lazic, Kate Houghton, Max Bayne, Martin J. Connor, Henry Tam, Hashim U. Ahmed, Taimur T. Shah and Tara D. Barwick
    Journal of Nuclear Medicine March 1, 2024, 65 (3) 379-385; DOI: https://doi.org/10.2967/jnumed.123.266527
  • <sup>18</sup>F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma
    You have access
    18F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma
    Sonia Mahajan, Christopher A. Barker, Audrey Mauguen, Sandra P. D’Angelo, Randy Yeh and Neeta Pandit-Taskar
    Journal of Nuclear Medicine June 1, 2022, 63 (6) 906-911; DOI: https://doi.org/10.2967/jnumed.121.262882
  • 
    <sup>11</sup>C-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence
    You have access
    11C-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence
    Asim K. Bag, Melissa N. Wing, Noah D. Sabin, Scott N. Hwang, Gregory T. Armstrong, Yuanyuan Han, Yimei Li, Scott E. Snyder, Giles W. Robinson, Ibrahim Qaddoumi, Alberto Broniscer, John T. Lucas and Barry L. Shulkin
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 664-671; DOI: https://doi.org/10.2967/jnumed.120.261891
  • You have access
    11C-Choline PET/CT in Recurrent Prostate Cancer: Retrospective Analysis in a Large U.S. Patient Series
    Laure Michaud, Karim A. Touijer, Audrey Mauguen, Michael J. Zelefsky, Michael J. Morris, Serge K. Lyashschenko, Jeremy C. Durack, John L. Humm, Wolfgang A. Weber and Heiko Schöder
    Journal of Nuclear Medicine June 1, 2020, 61 (6) 827-833; DOI: https://doi.org/10.2967/jnumed.119.233098
  • You have access
    The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer
    Jiajun Liu, Rengyun Liu, Xiaopei Shen, Guangwu Zhu, Biao Li and Mingzhao Xing
    Journal of Nuclear Medicine February 1, 2020, 61 (2) 177-182; DOI: https://doi.org/10.2967/jnumed.119.227652
  • You have access
    18F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate Cancer
    Olayinka A. Abiodun-Ojo, Akinyemi A. Akintayo, Oladunni O. Akin-Akintayo, Funmilayo I. Tade, Peter T. Nieh, Viraj A. Master, Mehrdad Alemozaffar, Adeboye O. Osunkoya, Mark M. Goodman, Baowei Fei and David M. Schuster
    Journal of Nuclear Medicine November 1, 2019, 60 (11) 1531-1536; DOI: https://doi.org/10.2967/jnumed.119.227033
  • You have access
    Immediate Postablation 18F-FDG Injection and Corresponding SUV Are Surrogate Biomarkers of Local Tumor Progression After Thermal Ablation of Colorectal Carcinoma Liver Metastases
    Francois H. Cornelis, Elena N. Petre, Efsevia Vakiani, David Klimstra, Jeremy C. Durack, Mithat Gonen, Joseph Osborne, Stephen B. Solomon and Constantinos T. Sofocleous
    Journal of Nuclear Medicine September 1, 2018, 59 (9) 1360-1365; DOI: https://doi.org/10.2967/jnumed.117.194506
  • You have access
    68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning
    Jeremie Calais, Johannes Czernin, Minsong Cao, Amar U. Kishan, John V. Hegde, Narek Shaverdian, Kiri Sandler, Fang-I Chu, Chris R. King, Michael L. Steinberg, Isabel Rauscher, Nina-Sophie Schmidt-Hegemann, Thorsten Poeppel, Philipp Hetkamp, Francesco Ceci, Ken Herrmann, Wolfgang P. Fendler, Matthias Eiber and Nicholas G. Nickols
    Journal of Nuclear Medicine February 1, 2018, 59 (2) 230-237; DOI: https://doi.org/10.2967/jnumed.117.201749

Pages

  • Next
  • 1
  • 2
SNMMI

© 2025 SNMMI

Powered by HighWire